期刊
WORLD JOURNAL OF DIABETES
卷 5, 期 2, 页码 89-96出版社
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.4239/wjd.v5.i2.89
关键词
Insulin; Inflammation; Hyperglycemia
资金
- The State Key Program of National Natural Science Foundation of China [81030005]
- High Technology Research and Development Program of China [2014AA020542]
- National Natural Science Foundation of China [31371150]
Hyperglycemia, a commonly exhibited metabolic disorder in critically ill patients, activates the body's inflammatory defense mechanism, causing the waterfall release of numerous inflammatory mediators and cytokines, and eventually leads to organ damage. As the only glucose-lowering hormone in the body, insulin not only alleviates the detrimental effects of hyperglycemia through its metabolic regulation, but also directly modulates inflammatory mediators and acts upon immune cells to enhance immunocompetence. In this sense, hyperglycemia is pro-inflammatory whereas insulin is anti-inflammatory. Therefore, during the past 50 years, insulin has not only been used in the treatment of diabetes, but has also been put into practical use in dealing with cardiovascular diseases and critical illnesses. This review summarizes the recent advances regarding the anti-inflammatory effects of insulin in both basic research and clinical trials, with the hope of aiding in the design of further experimental research and promoting effective insulin administration in clinical practice. (C) 2014 Baishideng Publishing Group Co., Limited. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据